To access this element change to forms mode OFF
Grant Award View - GA79791
Immuno-genetic biomarkers of response in a prospective study of immune...
GA ID:
GA79791
Agency:
Department of Health and Aged Care
Approval Date:
21-Apr-2020
Publish Date:
26-May-2020
Category:
Health and Medical Research
Grant Term:
1-Jun-2020 to 31-May-2025
Value (AUD):
$1,393,575.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health Policy Research and Analysis
Grant Program:
2019_MRFF_Investigator Grants_funding_commencing_June 2020
Grant Activity:
Immuno-genetic biomarkers of response in a prospective study of immune checkpoint therapy in primary CNS lymphoma
Purpose:
Primary Central Nervous System Lymphoma (PCNSL) is a rare brain cancer with poor outcomes using standard available therapies. Even if cured patients are left with significant problems due to the intense therapy. There is emerging data that this cancer may develop due to the tumours ability to avoid immune detection in the brain and this study will try to understand how the immune system can be helped to eradicate the cancer cells
GO ID:
GO Title:
Investigator Grants: Medical Research Future Fund (MRFF) Priority Round
Internal Reference ID:
MRF1194324
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
QLD
Postcode:
Country:
AUSTRALIA